Brian Gazzard

1.3k total citations
37 papers, 797 citations indexed

About

Brian Gazzard is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Brian Gazzard has authored 37 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 17 papers in Virology and 12 papers in Emergency Medicine. Recurrent topics in Brian Gazzard's work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (17 papers) and HIV-related health complications and treatments (12 papers). Brian Gazzard is often cited by papers focused on HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (17 papers) and HIV-related health complications and treatments (12 papers). Brian Gazzard collaborates with scholars based in United Kingdom, United States and France. Brian Gazzard's co-authors include C Wastell, Nathan Clumeck, Andrew Miles, Willy Rozenbaum, Christopher Stone, Jan Gerstoft, T G Allen-Mersh, Sarah Moore, M Johnson and F. D. Goebel and has published in prestigious journals such as Journal of Clinical Oncology, Circulation Research and The British Journal of Psychiatry.

In The Last Decade

Brian Gazzard

35 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Gazzard United Kingdom 15 480 337 223 189 122 37 797
Annette Haberl Germany 18 499 1.0× 285 0.8× 310 1.4× 154 0.8× 125 1.0× 56 868
Mervyn Tyrer United Kingdom 15 668 1.4× 496 1.5× 227 1.0× 143 0.8× 72 0.6× 27 820
Peter Gute Germany 18 868 1.8× 688 2.0× 308 1.4× 216 1.1× 45 0.4× 35 1.2k
Jessica L. Castilho United States 15 502 1.0× 219 0.6× 253 1.1× 369 2.0× 58 0.5× 39 768
Daniel Podzamczer Spain 17 500 1.0× 258 0.8× 343 1.5× 175 0.9× 36 0.3× 35 821
Evelyn Hogg United States 16 794 1.7× 497 1.5× 488 2.2× 364 1.9× 142 1.2× 33 1.2k
J Falloon United States 7 454 0.9× 508 1.5× 400 1.8× 430 2.3× 42 0.3× 9 1.1k
Renfang Zhang China 18 413 0.9× 214 0.6× 331 1.5× 156 0.8× 78 0.6× 81 792
Yueming Li Australia 10 398 0.8× 373 1.1× 224 1.0× 157 0.8× 32 0.3× 19 633
P. de Truchis France 10 351 0.7× 251 0.7× 201 0.9× 147 0.8× 22 0.2× 20 589

Countries citing papers authored by Brian Gazzard

Since Specialization
Citations

This map shows the geographic impact of Brian Gazzard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Gazzard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Gazzard more than expected).

Fields of papers citing papers by Brian Gazzard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Gazzard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Gazzard. The network helps show where Brian Gazzard may publish in the future.

Co-authorship network of co-authors of Brian Gazzard

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Gazzard. A scholar is included among the top collaborators of Brian Gazzard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Gazzard. Brian Gazzard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taylor, Kirk A., et al.. (2020). HIV Antivirals Affect Endothelial Activation and Endothelial-Platelet Crosstalk. Circulation Research. 127(11). 1365–1380. 17 indexed citations
2.
3.
Gazzard, Brian, Pierre Marie Girard, Giovanni Di Perri, et al.. (2014). Long‐term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV‐1‐infected treatment‐naïve subjects ≥50 years. Journal of the International AIDS Society. 17(4S3). 19767–19767. 2 indexed citations
4.
Tebas, Pablo, Martin Fisher, Brian Gazzard, et al.. (2013). Efficacy of switching to rilpivirine/emtricitabine/tenofovir DF from boosted PI in HIV-1 virologically suppressed patients with or without the K103N. Journal of the International AIDS Society. 16(Suppl 1). 2 indexed citations
5.
6.
Gazzard, Brian. (2010). The SENSE Trial: Etravirine (ETR) shows fewer Neuropsychiatric Adverse Events than Efavirenz (EFV) in Treatment-naïve HIV-1 Infected Patients. 2 indexed citations
7.
Gazzard, Brian, et al.. (2010). Models for palliative care in sub-Saharan Africa. International Health. 2(2). 77–78. 2 indexed citations
8.
Leen, Clifford, Jonathan Ainsworth, J. Anderson, et al.. (2009). Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention? United Kingdom Collaborative HIV Cohort Study Group. UCL Discovery (University College London). 7 indexed citations
9.
Wildfire, Adrian, Justin Stebbing, & Brian Gazzard. (2007). Rights theory in a specific healthcare context: “Speaking ill of the dead”. Postgraduate Medical Journal. 83(981). 473–477. 1 indexed citations
10.
Hardy, Gareth, Nesrina Imami, Mark Nelson, et al.. (2007). A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapy. PubMed. 5(1). 6–6. 19 indexed citations
11.
Winston, Alan, David Back, Malte Schütz, et al.. (2006). Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteers. AIDS. 20(10). 1401–1406. 38 indexed citations
12.
Gold, Julian, Marijka Batterham, Hans Rekers, et al.. (2006). Effects of nandrolone decanoate compared with placebo or testosterone on HIV‐associated wasting. HIV Medicine. 7(3). 146–155. 39 indexed citations
13.
Stephan, Christoph, Marion Johnson, Brian Gazzard, et al.. (2004). Randomised comparison of maintenance therapy with trizivir [TZV] + Efavirenz [EFV] vs TZV in naïve HIV-1 infected subjects: TIME Study. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 1 indexed citations
14.
Hannan, Margaret M., Fernando Maltêz, Andrew Hayward, et al.. (2001). Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital. Journal of Hospital Infection. 47(2). 91–97. 32 indexed citations
15.
16.
Chapman, Kate, et al.. (1995). Testing patients for HIV before surgery: The views of doctors performing surgery. AIDS Care. 7(2). 125–128. 6 indexed citations
17.
Catalán, José, et al.. (1992). Eating Disorders in Men with HIV Infection. The British Journal of Psychiatry. 160(3). 404–407. 16 indexed citations
18.
Naylor, Paul H., Marcelo B. Sztein, Scott H. Maurer, et al.. (1991). Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine — HGP-30-KLH. International Journal of Immunopharmacology. 13. 117–127. 24 indexed citations
19.
Youle, M, David Hawkins, Charles Farthing, et al.. (1989). The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study.. PubMed. 70(262). 161–74. 19 indexed citations
20.
Gazzard, Brian. (1987). 6 Aids. Baillière s Clinical Gastroenterology. 1(3). 567–587. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annette Haberl Breakdown of academic impact, for papers by Mervyn Tyrer Breakdown of academic impact, for papers by Peter Gute Breakdown of academic impact, for papers by Jessica L. Castilho Breakdown of academic impact, for papers by Daniel Podzamczer Breakdown of academic impact, for papers by Evelyn Hogg Breakdown of academic impact, for papers by J Falloon Breakdown of academic impact, for papers by Renfang Zhang Breakdown of academic impact, for papers by Yueming Li Breakdown of academic impact, for papers by P. de Truchis
Rankless by CCL
2026